Zaid Almarzooq, M.B.,B.Ch.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart-Assist Devices | 3 | 2023 | 1194 | 1.200 |
Why?
|
Aortic Valve Stenosis | 6 | 2023 | 1965 | 1.100 |
Why?
|
Lipoprotein(a) | 2 | 2023 | 435 | 0.820 |
Why?
|
Myocardial Infarction | 5 | 2023 | 11727 | 0.760 |
Why?
|
Troponin | 2 | 2020 | 524 | 0.710 |
Why?
|
Heart Valve Prosthesis Implantation | 3 | 2023 | 1536 | 0.610 |
Why?
|
Heart Valve Prosthesis | 2 | 2023 | 1488 | 0.610 |
Why?
|
Cardiovascular System | 1 | 2024 | 832 | 0.560 |
Why?
|
Education, Distance | 1 | 2020 | 251 | 0.550 |
Why?
|
Pulmonary Embolism | 3 | 2023 | 2376 | 0.540 |
Why?
|
Hypercholesterolemia | 1 | 2022 | 1151 | 0.510 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2020 | 591 | 0.500 |
Why?
|
Prosthesis Implantation | 1 | 2019 | 642 | 0.490 |
Why?
|
Echocardiography, Transesophageal | 1 | 2020 | 1133 | 0.470 |
Why?
|
Calcinosis | 1 | 2022 | 1499 | 0.460 |
Why?
|
Aortic Valve | 6 | 2023 | 1922 | 0.400 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2291 | 0.390 |
Why?
|
Population Surveillance | 1 | 2021 | 2616 | 0.380 |
Why?
|
Stroke | 6 | 2024 | 9981 | 0.350 |
Why?
|
Acute Coronary Syndrome | 1 | 2023 | 2337 | 0.350 |
Why?
|
Kidney Failure, Chronic | 2 | 2021 | 2538 | 0.340 |
Why?
|
Brain Ischemia | 1 | 2022 | 3265 | 0.310 |
Why?
|
Coronary Disease | 1 | 2022 | 6077 | 0.290 |
Why?
|
Heart Failure | 7 | 2021 | 10900 | 0.290 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3670 | 0.290 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3255 | 0.280 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5751 | 0.270 |
Why?
|
Heart Diseases | 3 | 2024 | 2788 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3133 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.260 |
Why?
|
Prosthesis Design | 2 | 2023 | 2110 | 0.250 |
Why?
|
Coronary Artery Disease | 2 | 2022 | 6487 | 0.250 |
Why?
|
Cardiovascular Diseases | 4 | 2024 | 15165 | 0.250 |
Why?
|
United States | 15 | 2024 | 69872 | 0.230 |
Why?
|
Embolectomy | 1 | 2023 | 120 | 0.210 |
Why?
|
Humans | 38 | 2024 | 744343 | 0.210 |
Why?
|
Treatment Outcome | 10 | 2023 | 63114 | 0.200 |
Why?
|
Republic of Korea | 1 | 2023 | 539 | 0.190 |
Why?
|
Internship and Residency | 1 | 2021 | 5788 | 0.190 |
Why?
|
Pandemics | 2 | 2020 | 8388 | 0.190 |
Why?
|
Venous Thromboembolism | 2 | 2023 | 1671 | 0.180 |
Why?
|
Catheters | 1 | 2023 | 425 | 0.180 |
Why?
|
Medicare | 5 | 2023 | 6566 | 0.170 |
Why?
|
Thrombolytic Therapy | 3 | 2023 | 2161 | 0.170 |
Why?
|
Antihypertensive Agents | 2 | 2019 | 2046 | 0.170 |
Why?
|
Risk Factors | 8 | 2023 | 72290 | 0.160 |
Why?
|
Aged | 16 | 2023 | 163280 | 0.160 |
Why?
|
Aortic Valve Insufficiency | 1 | 2022 | 579 | 0.160 |
Why?
|
Heart | 2 | 2022 | 4467 | 0.160 |
Why?
|
Stroke Volume | 4 | 2021 | 5007 | 0.160 |
Why?
|
Shock, Cardiogenic | 1 | 2023 | 688 | 0.160 |
Why?
|
Anticoagulants | 2 | 2023 | 4599 | 0.140 |
Why?
|
Albuminuria | 1 | 2020 | 682 | 0.140 |
Why?
|
Regression Analysis | 2 | 2024 | 6459 | 0.140 |
Why?
|
Morbidity | 1 | 2021 | 1769 | 0.140 |
Why?
|
Preventive Health Services | 1 | 2020 | 575 | 0.130 |
Why?
|
Tetrazoles | 1 | 2021 | 835 | 0.130 |
Why?
|
Blood Pressure | 3 | 2020 | 8554 | 0.130 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 924 | 0.130 |
Why?
|
Registries | 2 | 2020 | 8089 | 0.120 |
Why?
|
Hemorrhage | 2 | 2023 | 3461 | 0.120 |
Why?
|
Mammary Arteries | 1 | 2014 | 70 | 0.120 |
Why?
|
Thromboembolism | 1 | 2020 | 986 | 0.120 |
Why?
|
American Heart Association | 3 | 2024 | 1056 | 0.120 |
Why?
|
Outpatients | 1 | 2022 | 1486 | 0.120 |
Why?
|
Fibrinolytic Agents | 1 | 2023 | 2158 | 0.110 |
Why?
|
Male | 17 | 2023 | 350118 | 0.110 |
Why?
|
Hospital Mortality | 2 | 2017 | 5317 | 0.110 |
Why?
|
Mortality | 2 | 2021 | 2864 | 0.110 |
Why?
|
Guideline Adherence | 1 | 2022 | 2266 | 0.100 |
Why?
|
Female | 17 | 2023 | 380194 | 0.100 |
Why?
|
Renal Dialysis | 1 | 2021 | 1786 | 0.100 |
Why?
|
Aspirin | 1 | 2023 | 3282 | 0.100 |
Why?
|
Kidney | 2 | 2024 | 7186 | 0.090 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2023 | 3068 | 0.090 |
Why?
|
Prognosis | 2 | 2021 | 29063 | 0.090 |
Why?
|
Hypertension | 3 | 2019 | 8480 | 0.090 |
Why?
|
Health Behavior | 1 | 2022 | 2636 | 0.090 |
Why?
|
Heart Ventricles | 1 | 2022 | 3821 | 0.090 |
Why?
|
Thrombosis | 1 | 2023 | 2968 | 0.080 |
Why?
|
Hospitalization | 3 | 2021 | 10262 | 0.080 |
Why?
|
Recurrence | 1 | 2020 | 8340 | 0.080 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15540 | 0.070 |
Why?
|
Quality Improvement | 1 | 2020 | 3749 | 0.070 |
Why?
|
Exercise | 1 | 2022 | 5615 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2014 | 2289 | 0.060 |
Why?
|
Insurance, Health | 1 | 2016 | 2494 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15076 | 0.060 |
Why?
|
Patient Discharge | 1 | 2016 | 3313 | 0.060 |
Why?
|
Atrial Fibrillation | 2 | 2018 | 5034 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2022 | 39050 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25043 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2022 | 77449 | 0.050 |
Why?
|
Body Mass Index | 1 | 2019 | 12720 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16365 | 0.050 |
Why?
|
Middle Aged | 9 | 2022 | 213383 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20129 | 0.050 |
Why?
|
Risk Assessment | 1 | 2020 | 23338 | 0.040 |
Why?
|
Acute Disease | 2 | 2022 | 7149 | 0.040 |
Why?
|
Adult | 6 | 2023 | 214055 | 0.040 |
Why?
|
Massachusetts | 2 | 2020 | 8663 | 0.040 |
Why?
|
International Classification of Diseases | 1 | 2022 | 867 | 0.040 |
Why?
|
Biphenyl Compounds | 1 | 2021 | 913 | 0.040 |
Why?
|
Drug Combinations | 1 | 2021 | 1959 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2022 | 57776 | 0.030 |
Why?
|
Prospective Studies | 1 | 2019 | 53288 | 0.030 |
Why?
|
Survival Rate | 2 | 2022 | 12788 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2021 | 1573 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2170 | 0.030 |
Why?
|
Comorbidity | 2 | 2017 | 10388 | 0.030 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2022 | 1390 | 0.030 |
Why?
|
Vascular Patency | 1 | 2014 | 886 | 0.030 |
Why?
|
Vaccination | 1 | 2023 | 3278 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2297 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2023 | 2987 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3584 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2902 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2021 | 5097 | 0.020 |
Why?
|
Anemia | 1 | 2017 | 1506 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3679 | 0.020 |
Why?
|
Time Factors | 2 | 2022 | 40075 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 9959 | 0.020 |
Why?
|
Adolescent | 3 | 2023 | 85781 | 0.020 |
Why?
|
Cohort Studies | 2 | 2018 | 40561 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12245 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10397 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7659 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6309 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 7729 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 12745 | 0.010 |
Why?
|
Young Adult | 2 | 2017 | 56430 | 0.010 |
Why?
|